Triple
T36571705
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | hepatitis C virus |
E902136
|
entity |
| Predicate | treatedBy |
P4714
|
FINISHED |
| Object |
NS5A inhibitors
NS5A inhibitors are a class of direct-acting antiviral drugs that block the nonstructural protein 5A of hepatitis C virus, helping to achieve high cure rates in chronic HCV infection.
|
E2189901
|
NE FINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: NS5A inhibitors | Statement: [hepatitis C virus, treatedBy, NS5A inhibitors]
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: NS5A inhibitors Triple: [hepatitis C virus, treatedBy, NS5A inhibitors]
Generated description
NS5A inhibitors are a class of direct-acting antiviral drugs that block the nonstructural protein 5A of hepatitis C virus, helping to achieve high cure rates in chronic HCV infection.
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69f76e6416708190a9754b8c52d4e453 |
completed | May 3, 2026, 3:48 p.m. |
| NER | Named-entity recognition | batch_69f7c2a0f01c81908e99834fba3e37c0 |
completed | May 3, 2026, 9:48 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_6a39f90e2bf88190ad0b92137c3f961c |
completed | June 23, 2026, 3:10 a.m. |
| NEDg | Description generation | batch_6a39fa087dc881908f4220377de4a91a |
completed | June 23, 2026, 3:14 a.m. |
| NED2 | Entity disambiguation (via description) | batch_6a39fa95a6ec8190a835a2a1b735c885 |
completed | June 23, 2026, 3:16 a.m. |
Created at: May 3, 2026, 4:11 p.m.